Valuation Bio-Rad Laboratories, Inc.
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 305.96 USD | +1.41% |
|
+2.55% | +0.98% |
| 01/07 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 03/06 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
Company Valuation: Bio-Rad Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 22,439 | 12,460 | 9,399 | 9,182 | 8,212 | 8,113 | - | - |
| Change | - | -44.47% | -24.57% | -2.31% | -10.57% | -1.21% | - | - |
| Enterprise Value (EV) 1 | 22,439 | 11,868 | 8,992 | 8,730 | 7,874 | 7,364 | 7,147 | 7,006 |
| Change | - | -47.11% | -24.24% | -2.91% | -9.8% | -6.49% | -2.94% | -1.98% |
| P/E | 5.38x | - | -14.8x | -5.03x | 10.9x | 36.8x | 36x | 36.2x |
| PBR | - | 1.27x | 1.05x | 1.41x | 1.11x | 1.18x | 1.14x | - |
| PEG | - | - | - | -0x | -0x | -0.5x | 15.76x | -51.34x |
| Capitalization / Revenue | 7.68x | 4.45x | 3.52x | 3.58x | 3.18x | 3.16x | 3.08x | 3.03x |
| EV / Revenue | 7.68x | 4.24x | 3.37x | 3.4x | 3.05x | 2.87x | 2.71x | 2.62x |
| EV / EBITDA | 33.1x | 17.8x | 16.8x | 18.2x | 17.4x | 18.5x | 16.8x | 15.8x |
| EV / EBIT | 39.3x | 22.7x | 23.7x | 26.4x | 25.3x | 27.6x | 24x | 21.8x |
| EV / FCF | 41.9x | 127x | 24x | - | - | 23.6x | 22.8x | 21.5x |
| FCF Yield | 2.39% | 0.79% | 4.17% | - | - | 4.23% | 4.39% | 4.65% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 140.6 | - | -21.82 | -65.36 | 27.85 | 8.32 | 8.51 | 8.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,923 | 2,802 | 2,671 | 2,566 | 2,583 | 2,567 | 2,635 | 2,676 |
| EBITDA 1 | 677.5 | 667.9 | 535.9 | 479.5 | 453.2 | 398.6 | 426.3 | 442.3 |
| EBIT 1 | 571.2 | 524 | 378.9 | 331.3 | 311.6 | 266.8 | 298 | 322 |
| Net income 1 | 4,246 | -3,628 | -637.3 | -1,844 | 759.9 | 224.8 | 229.7 | 228.3 |
| Net Debt 1 | - | -592.5 | -407.6 | -452.1 | -337.7 | -749 | -965.4 | -1,107 |
| Reference price 2 | 755.57 | 420.49 | 322.89 | 328.51 | 302.99 | 305.96 | 305.96 | 305.96 |
| Nbr of stocks (in thousands) | 29,918 | 29,824 | 29,145 | 27,997 | 26,975 | 26,762 | - | - |
| Announcement Date | 10/02/22 | 16/02/23 | 15/02/24 | 13/02/25 | 12/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 36.26x | 2.87x | 18.48x | -.--% | 811.28Cr | |
| 27.81x | 3.92x | 15.22x | 2.6% | 17TCr | |
| 18.69x | 3.28x | 11.53x | 3.61% | 11TCr | |
| 16.86x | 0.19x | 11.92x | 0.78% | 5.9TCr | |
| 32.11x | 7.81x | 20.41x | 1.25% | 5.22TCr | |
| 38.33x | 3.07x | 10.45x | 2.5% | 4.24TCr | |
| 37.48x | 1.37x | 12.05x | 0.26% | 3.31TCr | |
| 30.54x | 5.44x | 17.35x | -.--% | 2.88TCr | |
| 42.69x | 7.46x | 26.94x | 0.24% | 2.54TCr | |
| 23.32x | 3.41x | 12.26x | 1.24% | 2.06TCr | |
| Average | 30.41x | 3.88x | 15.66x | 1.25% | 5.49TCr | |
| Weighted average by Cap. | 27.47x | 3.75x | 14.68x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- BIO Stock
- Valuation Bio-Rad Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
